National MS Registry of Iran

Farsi

Articles (reference):

2024:

  1. Lifetime exposure to smoking and substance abuse may be associated with late-onset multiple sclerosis: a population-based case control study, https://doi.org/10.1186/s12883-024-03815-9
  2. Consanguineous marriage among familial multiple sclerosis subjects: A national registry-based study
  3. A national registry-based study of ethnic differences in people with multiple sclerosis in Iran, https://doi.org/10.1016/j.clineuro.2024.108216
  4. Time Interval between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-based Study Clinical Neurology and Neurosurgery, https://doi.org/10.1016/j.clineuro.2024.108221
  5. Investigation of pregnancy tendency, reproductive characteristics, and disability in females with multiple sclerosis: A secondary data analysis of the National registry in Iran

2023:

  1. The incidence and prevalence of crude and familial multiple sclerosis in Tehran, Iran in 2021/ Neurological Sciences, https://doi.org/10.1007/s10072-023-07043-w
  2. Factors associated with the number of months of delaying in multiple sclerosis diagnosis: Comparison of count regression models/ Current Journal of Neurology 2023; 22(2): 65-71, doi: http://dx.doi.org/10.18502/cjn.v22i2.13330
  3. Economic and Social Standing of Individuals in Iran Diagnosed with Multiple Sclerosis, https://doi.org/10.34172/aim.2023.xx
  4. The National Multiple Sclerosis Registry System of Iran (NMSRI): Aspects and Methodological Dimensions on March 14, 2023. https://doi.org/10.1016/j.msard.2023.104610
  5. Side Effects of First and Second Doses of Inactivated COVID-19 Vaccine in Multiple Sclerosis, https://doi.org/10.32598/CJNS.9.32.373.1
  6. Epidemiological parameters of multiple sclerosis in Chaharmahal- Bakhtiari province, Iran
  7. Late-onset multiple sclerosis in Iran: A report on demographic and disease characteristics, https://doi.org/10.1016/j.msard.2022.104493

2022:

  1. Investigating the pregnancy tendency, reproductive characteristics, and disability in female patients with multiple sclerosis: A secondary data analysis of nationwide MS registry of Iran
  2. Epidemiology of multiple sclerosis in Iran in 2021
  3. COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case–control study (2022) – https://doi.org/10.1016/j.medcli.2022.06.020
  4. Research Paper: COVID-19 and its Outcomes in Multiple Sclerosis Patients – Caspian Journal of Neurological Sciences, 2022, 8(2), pp. 98-103
  5. Global assessment of characteristics of multiple sclerosis registries; A systematic review – Multiple Sclerosis and Related Disorders 63 (2022) 103928
  6. Comparison of side effects of the first and second doses of Sinopharm vaccine in patients with multiple sclerosis in Kermanshah-Iran (2021) –  Journal of Neurology & Clinical Neuroscience 2022, Volume 06
  7. Prescription trends of disease-modifying treatments for multiple sclerosis in Iran over the past 30 years – https://doi.org/10.1016/j.msard.2022.103777
  8. A Report of Multiple Sclerosis Registry in Mazandaran Province 2019-2021 – J Mazandaran Univ Med Sci 2022; 32 (207): 95-101 (Persian)
  9. Epidemiology of familial multiple sclerosis in Iran: a national registry-based study – BMC Neurology (2022) 22:76 https://doi.org/10.1186/s12883-022-02609-1

2021:

  1. Explaining the individual challenges of women affected by neuromyelitis optica and multiple sclerosis: A comparative content analysis Study – Clinical Neurology and Neurosurgery 207 (2021) 106789
  2. Multiple sclerosis projection in Tehran, Iran using Bayesian structural time series – BMC Neurology (2021) 21:235
  3. Prevalence of multiple sclerosis and its risks in Tehran, Iran, in 2019 – Neurological Sciences
  4. Comparison of disability score estimation in multiple sclerosis patients with artificial neural network and decision tree models – Tehran University Medical Journal, July 2021; Vol. 79, No. 4: 299-305 (in Persian)
  5. Progressive multiple sclerosis patients require special attention as a group at risk for coronavirus infection. Basic & Clinical Neuroscience
  6. Characteristics of COVID-19 in patients with multiple sclerosis”. Multiple Sclerosis and Related Disorders 57 (2022) 103437, https://doi.org/10.1016/j.msard.2021.103437
  7. A program for COVID-19 databases promoting in multiple sclerosis national registry system in Iran. Current Journal of Neurology
  8. Prevalence of Multiple sclerosis and its clinical and demographic characteristics in Kurdish populations in western Iran (2020). Multiple Sclerosis and Related Disorders 57 (2022) 103441, https://doi.org/10.1016/j.msard.2021.103441

2020:

  1. Epidemiology of familial multiple sclerosis: A population-based study in Tehran during 1999–2018- Multiple Sclerosis and Related Disorders 43 (2020) 102178
  2. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999–2018- BMC Neurology (2020) 20:169
  3. Multiple Sclerosis Registry in Kermanshah Province, Iran 2018 – J Mazandaran Univ Med Sci 2020; 30 (189): 147-152 (in Persian)

2019:

  1. Pediatric multiple sclerosis and its familial recurrence: A population based study (1999–2017)- Multiple Sclerosis and Related Disorders 36 (2019) 101377
  2. Multiple Sclerosis in Tehran: Rising Prevalence alongside Stabilizing Incidence – True Increase or Enhanced Diagnosis? Arch Iran Med. August 2019;22(8):429-434
  3. Multiple sclerosis national registry system in Iran: Validity and reliability of a minimum data set- Multiple Sclerosis and Related Disorders 33 (2019) 158–161

2018:

  1. Increasing prevalence of familial recurrence of multiple sclerosis in Iran: a population based study of Tehran registry 1999–2015- BMC Neurology (2018) 18:15
  2. The prevalence, incidence and familial recurrence of multiple sclerosis in Tehran, Iran-Multiple Sclerosis and Related Disorders 25 (2018) 143